Results 181 to 190 of about 48,929 (237)
Some of the next articles are maybe not open access.
Interventional Cardiology Clinics, 2022
In-stent restenosis (ISR) remains a potential complication after percutaneous coronary intervention, even in the era of drug-eluting stents, and its treatment remains suboptimal. Neoatherosclerosis is an important component of the pathology of ISR and is accelerated in drug-eluting stents compared with bare-metal stents.
Kenji, Kawai +2 more
openaire +2 more sources
In-stent restenosis (ISR) remains a potential complication after percutaneous coronary intervention, even in the era of drug-eluting stents, and its treatment remains suboptimal. Neoatherosclerosis is an important component of the pathology of ISR and is accelerated in drug-eluting stents compared with bare-metal stents.
Kenji, Kawai +2 more
openaire +2 more sources
Stenting for in-stent restenosis
Catheterization and Cardiovascular Interventions, 2000Intravascular ultrasound studies have shown that additional stent implantation is the only percutaneous technique that allows for recovery of all the lumen area of the original implantation procedure. Despite this theoretical advantage, information on systematic additional stent implantation is still forthcoming, especially concerning the impact of new
D, Antoniucci +7 more
openaire +2 more sources
Evaluation and management of drug-eluting stent in-stent restenosis
Current Opinion in Cardiology, 2023Purpose of review In-stent restenosis (ISR) is the most common cause of stent failure. Although the rate of ISR is significantly lower with contemporary drug-eluting stents (DES), it remains a challenging clinical entity to treat. Recent findings In this
S. Parfrey +9 more
semanticscholar +1 more source
Management of In-stent Restenosis
Indian Journal of Cardiovascular Disease in Women, 2023Despite recent improvements in percutaneous coronary intervention (PCI), in-stent restenosis (ISR) — which accounts for 5–10% of all PCI procedures in contemporary clinical practice remains a substantial problem and the most frequent reason for stent ...
S. Chhabra, J. Majella
semanticscholar +1 more source
Intravascular Lithotripsy for Acute Stent Under-Expansion and In-Stent Restenosis: A Case Series.
Current problems in cardiology, 2022Coronary in-stent restenosis (ISR) has an incidence of about 10% of percutaneous coronary interventions (PCIs) performed in the United States. Traditional management strategies for ISR include balloon angioplasty with non-compliant or use of cutting ...
A. Thandra +4 more
semanticscholar +1 more source
Treatment of in-stent restenosis
International Journal of Cardiology, 2005Since its introduction in 1977, percutaneous coronary intervention (PCI) has revolutionized the treatment of coronary artery disease by providing a safe and feasible alternative to coronary bypass graft (CABG) surgery [1]. The subsequent development of coronary stents has had a further positive impact on the clinical effectiveness and predictability of
Thuraia, Nageh, Bernhard, Meier
openaire +2 more sources
Pathology of in-stent restenosis
Current Opinion in Lipidology, 1999The process of in-stent restenosis parallels wound healing responses. Stent deployment results in early thrombus deposition and acute inflammation, granulation tissue development, and ultimately smooth muscle cell proliferation and extracellular matrix synthesis.
R, Virmani, A, Farb
openaire +2 more sources
Stress induced self-rollable smart-stent-based U-health platform for in-stent restenosis monitoring.
In Analysis, 2022To date, several smart stents have been proposed to continuously detect biological cues, which is essential for tracking patients' critical vital signs and therapy. However, the proposed smart stent fabrication techniques rely on conventional laser micro-
Dong-Su Kim +5 more
semanticscholar +1 more source
In-stent Restenosis of drug-eluting Stents
Future Cardiology, 2013Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic ...
Sa'ar, Minha +2 more
openaire +2 more sources